Healthcare Sector: Herbalife Ltd. (NYSE:HLF) COO Feels Worth in Company’s Stock, Johnson & Johnson (NYSE:JNJ) Taps Gorsky as New Chairman

  on Dec 05,2012 Posted in Business News ,Featured
 
Share |
We're on   

Stockholders of Herbalife Ltd. (NYSE:HLF) ditched its stock six months back and have indicated low interest since. But one insider feels confident regarding the financial health of the nutrition-products supplier.

Herbalife‘s Chief Operating Officer Richard Goudis gave $3.1 million last month to buy 69,866 stock of his firm’s hammered stock, which exchanged 36% off its 52-week high.

In last trading session, Herbalife Ltd. (NYSE:HLF) surged 1.99% to close at $46.55 and its total volume during last trading session was 2.58 million shares. Its opening price was $45.95 and its shares hit the day high price of $46.68 and day low of $45.81.

Johnson & Johnson (NYSE:JNJ) has selected the present Chief Executive Alex Gorsky as the new chairman of its board of directors. Gorsky would undertake the chairman title and associated additional leadership duties on December 28th.

Johnson & Johnson (NYSE:JNJ) jumped 0.30% and closed at $69.86 with the total traded volume of 14.28 million shares. Stock’s 52 weeks high price was $72.74 and 52 weeks low price was $61.71.

JNJ has outstanding shares of 2.77 billion with the total market capitalization of $193.60 billion.

Barclays Capital confirmed their overweight rating on Gilead Sciences (NASDAQ: GILD) stock in a report published on Tuesday. They presently have a $76.00 target price on the stock.

Gilead Sciences, Inc. (NASDAQ:GILD) moved down -0.61% with the closing price of $74.16. The overall volume in the last trading session was 5.18 million shares. Its fifty two week range was $36.98-$76.28.

GILD is ahead of its 52 week low with 100.54% and its last month’s price volatility remained 2.31%. Its beta coefficient was 0.45 with a target price of $82.17. In its share capital GILD has 757.65 million outstanding shares while 751.93 million shares have been floated in market.

The price of CEL-SCI Corporation (NYSEAMEX:CVM) moved down -18.00% and finished the day at $0.287 on above average volume. The day started out with a lower opening price of $0.31 versus prior close of $0.35. The total number of shares traded on the latest trading day was about 9.83 million shares, and changed hands at average prices of $0.28 to $0.34 apiece. The shares declined about -1.03% since the start of 2012 and has a -10.31% fall in last three months. Narrowing down the performance period, the stock declined -22.43% for the month and a -15.59% drop over the week.

Galena Biopharma Inc (NASDAQ:GALE)’s shares touched a high of $2.43 before closing at $2.24, an increase of $0.20. The trading volume was 7.82 million shares. Since hitting a 52-week low of $0.36 on December 20, 2011, the stock has managed to stay 522.22% higher from that level. The latest gain caused shares to increase their 2012 gain to 376.60%.

 



 

Leave a Reply